Status:
UNKNOWN
The Impact of Low Pressure Pneumo in RARP II
Lead Sponsor:
Metro Health, Michigan
Conditions:
Prostate Cancer
Eligibility:
MALE
40+ years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate clinical significance of low pressure pneumoperitoneum during robotically assisted radical prostatectomy (RARP).
Detailed Description
Laparoscopic and robotic surgery has revolutionized post-operative outcomes across surgical specialties. However, the use of pneumoperitoneum comes with known risks given the change in physiological p...
Eligibility Criteria
Inclusion
- \- Male 40 years of age or older
- Diagnosis of prostate cancer
- Have been evaluated to be fit for proposed surgery
- Patients able to consent
Exclusion
- \- Patients unable to consent (cognitively impaired)
- • Non-English speaking
Key Trial Info
Start Date :
August 4 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2025
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT04394676
Start Date
August 4 2020
End Date
June 30 2025
Last Update
October 12 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Metro Health-University of Michigan Health
Wyoming, Michigan, United States, 49519